"EDA2R: Aging Biomarker and Inflammaging Target"

EDA2R May Be an Aging Biomarker and Inflammaging Target

By Josh Conway

Published on November 6, 2025

A Necessary Protein Gone Bad

EDA2R is a gene that plays a critical role in healthy skin development, as it is necessary for proper skin and hair follicle creation. However, this protein, a member of the inflammatory tumor necrosis factor (TNF) pathway, is also linked to various age-related diseases.

Research shows that animals with mutations in this gene suffer from a condition known as ectodermal dysplasia, which results in significant malformations in the skin and hair. While EDA2R is essential for life, its overexpression is associated with several detrimental effects, such as:

• Alopecia: Studies have demonstrated links between EDA2R and hair loss disorders.
• Muscle atrophy: The gene's overexpression has been connected to muscle wasting in cancer patients.
• Older age-related diseases: Implicit findings suggest that EDA2R may serve as a biomarker for biological aging.

Beyond the Skin

Initial studies revealed that EDA2R is expressed not only in hair and skin but also in the fat, vasculature, and immune system. A comprehensive tissue expression survey identified its high expression levels in reproductive and endocrine systems, indicating that EDA2R plays a versatile role across different biological systems.

Interestingly, EDA2R's locus is located near androgen-related genes on the X chromosome, contributing to its associations with male pattern baldness. Its expression levels also vary between genders, revealing a potential link to aging and highlighting its relevance as a biomarker.

Furthermore, researchers discovered three distinct pathways through which EDA2R induces inflammaging—a term to describe the low-grade inflammation that contributes to aging. These pathways include:

1. The canonical NF-κB pathway, activated through TRAF6.
2. The JNK pathway, also activated via TRAF6.
3. The non-canonical NF-κB pathway, activated by TRAF3.

All these pathways are known to contribute to inflammation, revealing how EDA2R is poised at a critical intersection of age-related health issues.

Associations with Age-Related Diseases

Research findings from various cohorts, animal models, and clinical studies provide compelling evidence linking EDA2R's expression to a range of inflammatory and age-related diseases:

A Potentially Difficult Target

Despite the intriguing connections between EDA2R and various health issues, targeting this protein therapeutically poses challenges due to its similarity to EDAR, another protein. There are two amino acid residues that differentiate EDA2R from EDAR, which complicates the development of specific drugs aimed solely at EDA2R.

Current strategies to modulate EDA2R levels include:

1. Diet: Nutritional interventions may provide a pathway to influence EDA2R expression.
2. Exercise: Maintaining physical activity levels can positively impact gene expression.
3. Ginkgolide B: A compound found in ginkgo biloba has been shown to reduce EDA2R expression in animal studies.

Moreover, several studies have demonstrated that fasting also contributes to reducing EDA2R levels, reinforcing the role of lifestyle factors in managing its expression.

Conclusion

In summary, the gene EDA2R serves a dual role in healthy development and dysfunction associated with aging. While manipulating this protein directly may prove challenging, the preliminary evidence suggests that adopting lifestyle interventions such as diet and exercise may provide effective means of modulating its effects. Ongoing research is essential to explore the clinical implications of EDA2R as a biomarker and its potential role in combating age-related decline and diseases.

Literature

[1] Mikkola, M. L. (2008). TNF superfamily in skin appendage development. Cytokine & growth factor reviews, 19(3-4), 219-230.

[2] Lee, J., & Tumbar, T. (2012). Hairy tale of signaling in hair follicle development and cycling. In Seminars in cell & developmental biology (Vol. 23, No. 8, pp. 906-916). Academic Press.

[3] Katthika, V. K., & Auerkari, E. I. (2018). Ectodermal Dysplasia. In 11th International Dentistry Scientific Meeting (IDSM 2017) (pp. 230-238). Atlantis Press.

[4] Dostert, C., Grusdat, M., Letellier, E., & Brenner, D. (2019). The TNF family of ligands and receptors: communication modules in the immune system and beyond. Physiological reviews, 99(1), 115-160.

[5] Bilgic, S. N., et al. (2023). EDA2R–NIK signaling promotes muscle atrophy linked to cancer cachexia. Nature, 617(7962), 827-834.

[6] Arif, M., et al. (2025). Global and tissue-specific transcriptomic dysregulation in human aging: Pathways and predictive biomarkers. GeroScience, 1-20.

[7] Bergqvist, C., et al. (2017). Genetics of syndromic and non-syndromic hereditary nail disorders. Clinical Genetics, 91(6), 813-823.

[8] Kanoni, S., et al. (2022). Implicating genes, pleiotropy, and sexual dimorphism at blood lipid loci through multi-ancestry meta-analysis. Genome biology, 23(1), 268.

[9] Prodi, D. A., et al. (2008). EDA2R is associated with androgenetic alopecia. Journal of Investigative Dermatology, 128(9), 2268-2270.

[10] Barbera, M. C., et al. (2025). Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses. Nature Communications, 16(1), 1898.

[11] Zoodsma, M., et al. (2025). A genetic map of human metabolism across the allele frequency spectrum. Nature Genetics, 1-11.

[12] Moneva-Sakelarieva, M., et al. (2025). The role of the transcription factor NF-kB in the pathogenesis of inflammation and carcinogenesis. Modulation capabilities. Pharmacia, 72, 1-13.

[13] Wu, N., et al. (2025). Research Progress on Anti-Inflammatory Mechanism of Inula cappa. International Journal of Molecular Sciences, 26(5), 1911.

[14] Kaltschmidt, C., et al. (2021). The transcription factor NF-κB in stem cells and development. Cells, 10(8), 2042.

[15] Kwack, M. H., et al. (2024). EDA-A2 increases lipid production in EDA2R-expressing human sebocytes. Journal of Dermatological Science, 113(1), 34-37.

[16] Arif, M., et al. (2025). Global and tissue-specific transcriptomic dysregulation in human aging: Pathways and predictive biomarkers. GeroScience, 1-20.

[17] Perez, K., et al. (2022). Single nuclei profiling identifies cell specific markers of skeletal muscle aging, frailty, and senescence. Aging (Albany NY), 14(23), 9393.

[18] Ma, L. Z., et al. (2025). Plasma proteomics identify novel biomarkers and dynamic patterns of biological aging. Journal of Advanced Research.

[19] Papier, K., et al. (2024). Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank. Nature Communications, 15(1), 4010.

[20] Qian, H., et al. (2025). Plasma Proteomics Linking Primary and Secondary diseases: Insights into Molecular Mediation from UK Biobank Data. medRxiv, 2025-08.

[21] Gong, J., et al. (2025). Unraveling the role of proteins in dementia: insights from two UK cohorts with causal evidence. Brain Communications, 7(2), fcaf097.

[22] Lee, C. W., et al. (2025). Ginkgolide B increases healthspan and lifespan of female mice. Nature aging, 5(2), 237-258.

[23] Fernandez‐Gonzalo, R., et al. (2020). Three months of bed rest induce a residual transcriptomic signature resilient to resistance exercise countermeasures. The FASEB Journal, 34(6), 7958-7969.

[24] Pietzner, M., et al. (2024). Systemic proteome adaptions to 7-day complete caloric restriction in humans. Nature metabolism, 6(4), 764-777.

We are a non-profit foundation, committed to providing free news and educational content. Your support enables us to continue this work. Every contribution counts, no matter how big or small.